From the Guidelines
Patients with overactive bladder who have failed conservative treatments in Albany, NY, should be offered sacral neuromodulation, such as Axonics therapy, by urologists or colorectal specialists. According to the latest guidelines from the American Urological Association, sacral neuromodulation is a recommended treatment option for patients with idiopathic overactive bladder who have not responded to or have experienced intolerable side effects from pharmacotherapy or behavioral therapy 1. To find a provider in Albany, NY, patients can:
- Contact major hospitals like Albany Medical Center or St. Peter's Hospital and ask for their urology or colorectal departments
- Search online for "Axonics therapy Albany NY" or "sacral neuromodulation Albany NY" to find local specialists
- Call their insurance company for in-network providers offering this treatment
- Consult their primary care doctor for a referral to an appropriate specialist Axonics therapy involves implanting a small neurostimulator device to modulate sacral nerve function and improve bladder control, and is typically considered after conservative treatments like medications and lifestyle changes have failed, as supported by the AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder 1.
The advantages of sacral neuromodulation, including Axonics therapy, include high success rates, durable efficacy, and excellent patient satisfaction, making it a viable option for patients with overactive bladder who have failed other treatments 1. By prioritizing patient preferences and values, healthcare providers can craft personalized treatment plans that align with patient goals, potentially enhancing the effectiveness of overactive bladder management.
In terms of specific details, the Axonics therapy involves an evaluation, test stimulation period, and then permanent implantation if successful, with follow-up appointments needed to adjust stimulation settings for optimal results. Overall, sacral neuromodulation, such as Axonics therapy, is a recommended treatment option for patients with overactive bladder who have failed conservative treatments, and patients in Albany, NY, should consult with urologists or colorectal specialists to discuss this option.
From the Research
Overview of Axonics Sacral Neuromodulation Therapy
- Axonics Sacral Neuromodulation therapy is used to treat various conditions, including urinary urgency incontinence, fecal incontinence, and overactive bladder 2, 3, 4.
- The therapy involves the use of a rechargeable sacral neuromodulation system, which is designed to deliver therapy for at least 15 years 2, 5.
Conditions Treated with Axonics Sacral Neuromodulation Therapy
- Urinary urgency incontinence: The Axonics r-SNM System has been shown to be effective in treating urinary urgency incontinence, with 90% of participants experiencing clinically and statistically significant improvements in symptoms 2.
- Fecal incontinence: The Axonics rechargeable SNM system has been shown to be effective in treating fecal incontinence, with 87% of participants experiencing a 50% or greater reduction in fecal incontinence episodes 3.
- Overactive bladder: The Axonics SNM System has been shown to be safe and effective in treating overactive bladder, with improvements in symptoms and quality of life 4.
Use of Axonics Sacral Neuromodulation Therapy in Albany, NY
- There is no specific information available on the use of Axonics Sacral Neuromodulation therapy in Albany, NY.
- However, the therapy is available in various medical centers and hospitals, and patients can consult with their healthcare providers to determine if it is a suitable treatment option for their condition.
Benefits and Limitations of Axonics Sacral Neuromodulation Therapy
- Benefits: The Axonics Sacral Neuromodulation therapy has several benefits, including its rechargeable design, which minimizes the need for repeat surgery, and its ability to improve symptoms and quality of life 2, 4, 5.
- Limitations: The therapy is not without limitations, and surgical revision may still be necessary in some cases 5. Additionally, the long-term efficacy and safety of the therapy require further study.